Zenas BioPharma grants 125K options to officer
Zenas BioPharma, Inc. reported that officer Jennifer A. Fox received equity awards in the form of an option grant and common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Zenas BioPharma, Inc. reported that officer Jennifer A. Fox received equity awards in the form of an option grant and common shares. On June 15, 2026, she was granted 125,000 stock options to buy common stock at $18.71 per share, expiring on June 15, 2036. The option vests 25% on June 15, 2027, then in equal monthly installments over the following 36 months, subject to continued service. On February 5, 2026, she also acquired 1,592 common shares at $13.35 under the company’s 2024 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c).
Insider Trade Summary
Grant/Award: 126,592 shares
Grant/Award
2 txns
Insider
Fox Jennifer A.
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 125,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,592 | $13.35 | $21K |
Holdings After Transaction:
Stock Option (Right to Buy) — 125,000 contracts (Direct);
Common Stock — 1,592 shares (Direct)
Footnotes (2)
- F1. Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026 in transactions that were exempt under Rule 16b-3(c).
- F2. The option vests as to 25% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.
Key Figures
Option grant size: 125,000 options
Option exercise price: $18.71 per share
Option expiration: June 15, 2036
+2 more
5 metrics
Option grant size
125,000 options
Granted June 15, 2026 to buy common stock
Option exercise price
$18.71 per share
Stock option strike price
Option expiration
June 15, 2036
Stock option term end date
ESPP shares acquired
1,592 shares
Common stock acquired February 5, 2026
ESPP purchase price
$13.35 per share
Common stock under 2024 Employee Stock Purchase Plan
Key Terms
Employee Stock Purchase Plan, Rule 16b-3(c), stock option, vesting commencement date
4 terms
Employee Stock Purchase Plan financial
"Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(c) regulatory
"in transactions that were exempt under Rule 16b-3(c)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
stock option financial
"The option vests as to 25% of the underlying shares of common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting commencement date financial
"the first anniversary of the vesting commencement date, and as to the remaining shares"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Jennifer A. Fox report acquiring in ZBIO Form 4?
Jennifer A. Fox reported a grant of 125,000 stock options and an acquisition of 1,592 common shares. The options have a $18.71 exercise price, while the shares were acquired at $13.35 under Zenas BioPharma’s 2024 Employee Stock Purchase Plan.
What are the terms of Jennifer A. Fox’s 125,000 Zenas BioPharma stock options?
Fox’s 125,000 stock options allow her to buy common stock at $18.71 per share and expire June 15, 2036. They vest 25% on June 15, 2027, then in equal monthly installments over 36 months, contingent on her continued service.
When do Jennifer A. Fox’s Zenas BioPharma stock options expire and start vesting?
The 125,000 stock options expire on June 15, 2036. Vesting begins June 15, 2027, when 25% of the underlying shares vest, with the remaining shares vesting in equal monthly installments over the next 36 months, subject to continued service.
What is the nature of Jennifer A. Fox’s February 5, 2026 ZBIO stock acquisition?
On February 5, 2026, Fox acquired 1,592 Zenas BioPharma common shares at $13.35 per share through the 2024 Employee Stock Purchase Plan. The filing notes the transaction was exempt under Rule 16b-3(c), indicating a compensation-related acquisition rather than an open-market trade.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates